These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27453120)

  • 1. [Discussion of breast cancer screening model in China].
    Li WQ; Li R; Liu PF; Huang YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1039-43. PubMed ID: 27453120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overdiagnosis in mammography screening for breast cancer].
    Huang YB; Yang L; Song FJ; Chen KX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1574-1578. PubMed ID: 29141352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
    Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
    J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Breast Cancer.
    Niell BL; Freer PE; Weinfurtner RJ; Arleo EK; Drukteinis JS
    Radiol Clin North Am; 2017 Nov; 55(6):1145-1162. PubMed ID: 28991557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Risk Assessment Models and High-Risk Screening.
    Barke LD; Freivogel ME
    Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Pan-Canadian study of mammography screening and mortality from breast cancer.
    Narod SA; Giannakeas V; Miller AB
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855706
    [No Abstract]   [Full Text] [Related]  

  • 14. How best to determine the mortality benefit from screening mammography: dueling results and methodologies from Canada.
    Harris RP
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274580
    [No Abstract]   [Full Text] [Related]  

  • 15. Summaries for patients: Overdiagnosis of invasive breast cancer with mammography screening.
    Ann Intern Med; 2012 Apr; 156(7):I58. PubMed ID: 22473444
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
    Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
    JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence to Support Screening Women in Their 40s.
    Ray KM; Price ER; Joe BN
    Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Performance of Synthesized Two-dimensional Mammography Combined with Tomosynthesis in a Large Screening Population.
    Aujero MP; Gavenonis SC; Benjamin R; Zhang Z; Holt JS
    Radiology; 2017 Apr; 283(1):70-76. PubMed ID: 28221096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence to Support Screening Women Annually.
    Eby PR
    Radiol Clin North Am; 2017 May; 55(3):441-456. PubMed ID: 28411672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.